Global research trends in immunotherapy for non-small cell lung cancer patients with KRAS mutations: a bibliometric analysis.

Front Oncol · 2024 · PMC11137258 · PMID 38817907

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Patients with KRAS-G12D and KRAS-G12A mutations showed a shorter median progression-free survival (mPFS), which did not reach statistical significance ( 40 ).

also in 111,027 other papers

an increasing trendno p-value reported

The results indicate an increasing trend in the number of publications, suggesting growing interest in this topic, particularly due to recent advancements in the field of immunotherapy for patients carrying KRAS mutations.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.